Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

All filings by Shenzhen Hepalink Pharmaceutical Group Co., Ltd. on record concern Resverlogix Corp. Between 20 July 2015 and 14 August 2020, the trades on record add up to 6 filings.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The record was last updated on 17 August 2020 with a transaction in Resverlogix Corp. Typically, a trade is published a median of 3 days after it takes place. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SEDI. Past trades are no guide to future returns.